PVLA
Palvella Therapeutics
PVLA
PVLA
181 hedge funds and large institutions have $1.65B invested in Palvella Therapeutics in 2026 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
29.57% more ownership
Funds ownership: 82.45% → 112.03% (+30%)
29% more funds holding
Funds holding: 140 → 181 (+41)
Holders
181
Holding in Top 10
6
Calls
$53.5M
Puts
$14.2M
Top Buyers
| 1 | +$41.6M | |
| 2 | +$39M | |
| 3 | +$28.3M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$27.2M |
| 5 |
Jennison Associates
New York
|
+$26.4M |
Top Sellers
| 1 | -$40.8M | |
| 2 | -$27.9M | |
| 3 | -$13.4M | |
| 4 |
Morgan Stanley
New York
|
-$9.67M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$6.92M |
